Review maps LL-37's dual proapoptotic and prosurvival signaling roles
Authors say the cathelicidin's effect on programmed cell death flips with cell type and peptide concentration, complicating therapeutic use.
PR
By Priya Raman · Science Reporter
Sep 18 20:00 ETSource: International journal of molecular sciences
The wire
- 01A review in the International Journal of Molecular Sciences summarizes how human cathelicidin LL-37 modulates apoptosis, with effects varying by cell type and peptide concentration, and covers LL-37 derivatives.
- 02LL-37 is tracked by readers as an immune peptide; the review underlines that direction of effect is context-dependent rather than uniformly protective.
- 03This is a narrative review, not new experimental data. The authors frame mechanistic understanding as a prerequisite for therapeutic application, including in cancer.
From the source
Read at pubmed.ncbi.nlm.nih.govApoptosis Modulation by LL-37: From Mitochondrial Cell Death to Prosurvival Signaling
International journal of molecular sciences · 2026 Sep 19 · Voronko OE, Novikova VS, Klychkova OO et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42794783/
